Compare RNTX & OPAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNTX | OPAD |
|---|---|---|
| Founded | 2001 | 2015 |
| Country | United States | United States |
| Employees | 10 | 140 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.9M | 35.5M |
| IPO Year | N/A | N/A |
| Metric | RNTX | OPAD |
|---|---|---|
| Price | $1.70 | $0.88 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $10.00 | $1.83 |
| AVG Volume (30 Days) | 118.7K | ★ 668.9K |
| Earning Date | 05-14-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $32.08 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.02 | $0.57 |
| 52 Week High | $2.22 | $6.35 |
| Indicator | RNTX | OPAD |
|---|---|---|
| Relative Strength Index (RSI) | 69.15 | 64.94 |
| Support Level | $1.08 | $0.71 |
| Resistance Level | $2.18 | $0.90 |
| Average True Range (ATR) | 0.19 | 0.07 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 83.78 | 96.91 |
Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services, including mortgage, listing, renovation, and buyer representation services.